{
}
Teva Pharmaceutical Industries reported Q3 2024 revenue of $4.33 billion, a 12.5% increase year-over-year, surpassing estimates by 6.12%. The EPS rose to $0.69, beating expectations by 6.15%. Key geographic revenues showed varied performance, with U.S. sales at $2.23 billion (+11.1%) and international markets generating $613 million (+26.4%).
The global small-molecule injectable drugs market reached $188.9 billion in 2021, with a projected growth rate of 8% CAGR, expected to hit $837.8 billion by 2030. North America leads the market with a 37% share, driven by increased R&D and product approvals, while Europe is anticipated to grow the fastest due to rising demand for minimally invasive procedures. Intravenous injections accounted for 30% of the market, highlighting their critical role in rapid drug administration.
The ketoconazole market, valued at $106.24 million in 2022, is projected to grow at a CAGR of 3.1% through 2030, driven by rising demand for skin care drugs and increased product launches. The oral ketoconazole segment is expected to see significant growth, particularly in the APAC region, due to a busy lifestyle and a growing population. Major players include Mylan Inc., Johnson & Johnson, and Teva Pharmaceutical Industries.
Teva Pharmaceutical Industries Ltd. (TEVA) has significantly outperformed the Medical sector this year, returning approximately 76.1% compared to the sector's average gain of 6.6%. With a Zacks Rank of #2 (Buy) and an improved earnings outlook, TEVA stands out in the Medical - Generic Drugs industry, which has seen a 19.2% increase. In contrast, Addus HomeCare (ADUS) has also excelled, returning 40.1% and holding a Zacks Rank of #1 (Strong Buy).
Teva Pharmaceutical Industries Ltd. (TEVA) has significantly outperformed the Medical sector this year, gaining approximately 67.5% compared to the sector's average of 7.5%. With a Zacks Rank of #2 (Buy) and an improved earnings outlook, Teva stands out in the Medical - Generic Drugs industry, which has seen an average gain of 16.7%. Investors should keep an eye on both Teva and Adaptive Biotechnologies, which has also shown strong performance.
טבע תעשיות פרמצבטיות Ltd.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
teva pharmaceutical industries reports strong q3 earnings with revenue growth
15:30 06.11.2024
global small molecule injectable drugs market trends and regional insights 2021
United States Dollar
Pfizer Inc.
Novartis AG
טבע תעשיות פרמצבטיות Ltd.
Aurobindo Pharma Limited
Merck & Co., Inc.
FRA
RUS
GBR
ITA
ESP
USA
KOR
SAU
JPN
MEX
ARE
ZAF
BRA
ARG
CHN
QAT
AUS
IND
DEU
CAN
Merck & Co
Teva Pharmaceutical Industries Ltd.
Pfizer Inc.
Novartis AG
Inc.
AstraZeneca Plc.
Show more
22:59 28.10.2024
ketoconazole market growth driven by product launches and rising demand
United States Dollar
Johnson & Johnson Services Inc.
Strides Pharma Science Limited
Sandoz Group AG
Almirall, S.A.
טבע תעשיות פרמצבטיות Ltd.
Taro Pharmaceutical Industries Ltd.
Mylan Inc.
Johnson & Johnson Services
Almirall
Teva Pharmaceutical Industries Ltd.
Inc.
Almirall, SA
Taro Pharmaceutical Industries Ltd.
Mylan Inc.
Show more
23:08 27.10.2024
Teva Pharmaceutical Industries Outperforms Medical Sector with Strong Year-to-Date Returns
15:40 23.10.2024
teva pharmaceutical industries significantly outperforms medical sector in 2023
09:00 07.10.2024
Trending
Subcategory
Startups & Entrepreneurship
Corporate News
Industry Trends
Retail and Consumer Goods
Supply Chain Management
Global Trade Developments
Stock Market Updates
Industry Mergers & Acquisitions
AI Applications
Private Equity Deals
Funding Rounds & Investments
AI Innovations
Fintech Startups
Energy Sector Developments
Government Economic Policies
Emerging Startups
Global Financial Events
CEO Changes
Central Bank Actions
Commodities
Countries:
Companies:
Apple Inc.
Google Inc.
Tesmec S.p.A.
Tesla, Inc.
Amazon.com, Inc.
OpenAI ERC USD
Walmart Inc.
Microsoft Corporation
Foxconn Technology Co., Ltd.
Hollywood Bowl Group PLC
NASDAQ Composite
Wise plc
Mastercard Inc
Alphabet Inc.
SWIGGY LIMITED
Mistral 1
NVIDIA Corporation
Nippon Steel Corp
CCTV 50 CSR
Medtronic plc
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
British Pound Sterling
Japanese Yen
United Arab Emirates Dirham
Vietnamese Đồng
New Zealand Dollar
Thai Baht
Australian Dollar
Indonesian Rupiah
Singapore Dollar
Saudi Riyal
Omani Rial
Bahraini Dinar
Qatari Riyal
Algerian Dinar
Egyptian Pound
People: